VIVUS, Inc.

VVUS

Statistics

$0.48Share Price
$51 MMarket Cap
124.0%EBIT / EV
N/AFCF / EV
626.8%ROIC
N/ACash ROIC
18.2%3yr Avg Revenue Growth
7.47Current Ratio
star logo

Business Model Diligence

We do not yet have Business Model Diligence for this stock.

Statistical Diligence

check mark The EBIT / Enterprise Value of 124.0% ranks as Suspicious.
x mark Cannot calculate Free Cash Flow / Enterprise Value, company has negative Free Cash Flow.
check mark The Return on Invested Capital Value of 626.8% ranks as Suspicious.
x mark Cannot calculate Cash Return on Invested Capital, company has negative Free Cash Flow.
check mark The 3 Year Average Revenue Growth Value of 18.2% ranks as Above Average.
check mark Near-term Financial Health appears to be Very Good. The Current Ratio is 7.47.

Company Description

VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. Its products include Qsymia and STENDRA/SPEDRA. The company was founded by Virgil A. Palace in April 16, 1991 and is headquartered in Mountain View, CA.

Calculations

You must have a MagicDiligence Membership to view the Calculations for this stock. If you are already a member, you need to log in first.
Tracking Portfolios
blue wand Magic Recipe 33.56%
purple wand Deep Value 26.96%
orange wand Quality Growth 54.79%
green wand Green Team 16.01%
red dot Red Rating 8.00%
yellow dot Yellow Rating 20.92%
green dot Green Rating 28.22%
New Spell Stocks
blue wand Ubiquiti Networks, Inc. (UBNT)
blue wand Cambrex Corporation (CBM)
purple wand New Stocks Added!
orange wand New Stocks Added!